Top Growth Companies With High Insider Ownership May 2025

Simply Wall St

As the U.S. markets navigate a mixed trading environment with the S&P 500 and Dow Jones Industrial Average aiming to extend their winning streaks, investors are closely watching for signals from the Federal Reserve on interest rates amid ongoing tariff concerns. In such a climate, growth companies with high insider ownership can offer unique insights into potential resilience and alignment of interests between company leadership and shareholders.

Top 10 Growth Companies With High Insider Ownership In The United States

NameInsider OwnershipEarnings Growth
Super Micro Computer (NasdaqGS:SMCI)14.1%34.1%
Hims & Hers Health (NYSE:HIMS)13.1%21.9%
Duolingo (NasdaqGS:DUOL)14.3%39%
FTC Solar (NasdaqCM:FTCI)32.7%65.4%
Credo Technology Group Holding (NasdaqGS:CRDO)12.2%65.1%
Niu Technologies (NasdaqGM:NIU)36%82.8%
Astera Labs (NasdaqGS:ALAB)15.3%61.4%
Clene (NasdaqCM:CLNN)19.4%64%
BBB Foods (NYSE:TBBB)16.2%29.9%
Upstart Holdings (NasdaqGS:UPST)12.6%100.2%

Click here to see the full list of 203 stocks from our Fast Growing US Companies With High Insider Ownership screener.

Let's uncover some gems from our specialized screener.

ASP Isotopes (NasdaqCM:ASPI)

Simply Wall St Growth Rating: ★★★★★☆

Overview: ASP Isotopes Inc. is a development stage advanced materials company focused on the production, distribution, marketing, and sale of isotopes with a market cap of $420.16 million.

Operations: The company generates revenue through its segments, with $0.20 million from Nuclear Fuels and $3.94 million from Specialist Isotopes and Related Services.

Insider Ownership: 25.3%

ASP Isotopes, despite a volatile share price and recent shareholder dilution, shows significant growth potential with forecasted revenue increases of 40.2% annually and expected profitability within three years. Recent developments include a $25 million equity offering and a $100 million shelf registration, aimed at supporting its expansion in isotope production facilities using proprietary technology. The company's strategic focus on supplying isotopes for medical and nuclear applications positions it well in emerging markets with supply chain challenges.

NasdaqCM:ASPI Ownership Breakdown as at May 2025

Organogenesis Holdings (NasdaqCM:ORGO)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Organogenesis Holdings Inc. is a regenerative medicine company that develops, manufactures, and commercializes products for advanced wound care and surgical and sports medicine markets in the United States, with a market cap of $669.65 million.

Operations: The company's revenue is primarily derived from its regenerative medicine segment, which generated $482.04 million.

Insider Ownership: 37.6%

Organogenesis Holdings, recently added to the S&P Biotechnology Select Industry Index, shows potential for growth despite a volatile share price and significant insider selling in the past three months. The company reported a substantial increase in quarterly sales to US$126.66 million and returned to profitability with net income of US$7.67 million. While revenue is expected to grow at 8.6% annually, slower than some high-growth peers, it remains above the overall U.S. market rate of 8.4%.

NasdaqCM:ORGO Ownership Breakdown as at May 2025

AST SpaceMobile (NasdaqGS:ASTS)

Simply Wall St Growth Rating: ★★★★★★

Overview: AST SpaceMobile, Inc. designs and develops the BlueBird satellite constellation in the United States, with a market cap of $8.60 billion.

Operations: The company's revenue is primarily derived from its Wireless Communications Equipment segment, totaling $4.42 million.

Insider Ownership: 13.5%

AST SpaceMobile, with high insider ownership, is poised for rapid revenue growth at 56.6% annually, outpacing the U.S. market. Despite recent legal challenges and a US$300 million net loss in 2024, the company is strategically expanding through partnerships like its agreement with Vodafone and collaboration with NSF to enhance satellite communications. The company's innovative technology targets underserved areas but faces financial constraints with less than a year of cash runway and recent shareholder dilution.

NasdaqGS:ASTS Earnings and Revenue Growth as at May 2025

Next Steps

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Valuation is complex, but we're here to simplify it.

Discover if AST SpaceMobile might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com